Get started
Author

Qiang Xia

Observed names: Q Xia, Q. Xia
ORCID: 0000-0002-9199-9723
Observed ORCIDs: 0000-0002-9199-9723, 0000-0001-9482-6951
OpenAlex ID: A5101740460
Autocrine CTHRC1 Activates Hepatic Stellate Cells and Promotes Liver Fibrosis by Activating TGF-β Signaling
2018 · Jun Li, Yahui Wang, et al. · EBioMedicine · 108
Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy
2024 · Ziyi Li, Rhea Pai, et al. · Nature Cancer · 98
Submassive hepatic necrosis distinguishes HBV-associated acute on chronic liver failure from cirrhotic patients with acute decompensation
2015 · Hai Li, Qiang Xia, et al. · Journal of Hepatology · 93
Defective Initiation of Liver Regeneration in Osteopontin-Deficient Mice after Partial Hepatectomy due to Insufficient Activation of IL-6/Stat3 Pathway
2015 · Yankai Wen, Dechun Feng, et al. · International Journal of Biological Sciences · 72
Rapamycin Protection of Livers From Ischemia and Reperfusion Injury Is Dependent on Both Autophagy Induction and Mammalian Target of Rapamycin Complex 2-Akt Activation
2014 · Jianjun Zhu, Tianfei Lu, et al. · Transplantation · 60
HRG inhibits liver cancer lung metastasis by suppressing neutrophil extracellular trap formation
2023 · Yanze Yin, Huijuan Dai, et al. · Clinical and Translational Medicine · 52
PDF
Multi-region sequencing with spatial information enables accurate heterogeneity estimation and risk stratification in liver cancer
2022 · Chen Yang, Senquan Zhang, et al. · Genome Medicine · 45
PDF
DNA methylation-mediated silencing of matricellular protein dermatopontin promotes hepatocellular carcinoma metastasis by α3β1 integrin-Rho GTPase signaling
2014 · Ying Fu, Ming-Xuan Feng, et al. · Oncotarget · 44
PDF
Transplantation for EASL-CLIF and APASL acute-on-chronic liver failure (ACLF) patients: The TEA cohort to evaluate long-term post-Transplant outcomes
2022 · Lei Xia, Zi-yun Qiao, et al. · EClinicalMedicine · 39
PDF
Targeting Glutamine Metabolism Ameliorates Autoimmune Hepatitis via Inhibiting T Cell Activation and Differentiation
2022 · Qiang Yu, Honghu Tu, et al. · Frontiers in Immunology · 38
Liver organoids: established tools for disease modeling and drug development
2023 · Xi-Cheng Sun, De-fu Kong, et al. · Hepatology Communications · 37
Pembrolizumab in combination with LEnvatinib in participants with hepatocellular carcinoma before liver transplant as Neoadjuvant TherapY—PLENTY pilot study
2024 · Zicheng Lv, Xuelin Xiang, et al. · International Journal of Surgery · 31
Effect of infiltrating immune cells in tumor microenvironment on metastasis of hepatocellular carcinoma
2023 · Yiwen Chen, Yuhang Zhou, et al. · Cellular Oncology · 30
HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinoma
2015 · Feng Xue, Brandon W. Higgs, et al. · Journal of Translational Medicine · 30
PDF
Association between Metabolic Dysfunction-associated Fatty Liver Disease and Cognitive Impairment
2022 · Qiang Yu, Ruixin He, et al. · Journal of Clinical and Translational Hepatology · 28
PDF
Hepatocyte nuclear factor 4A improves hepatic differentiation of immortalized adult human hepatocytes and improves liver function and survival
2017 · Hua-Lian Hang, Xin-Yu Liu, et al. · Experimental Cell Research · 28
Aggregation‐Induced Emission (AIE) and Magnetic Resonance Imaging Characteristics for Targeted and Image‐Guided siRNA Therapy of Hepatocellular Carcinoma
2022 · Yu‐chen Hou, Chao Zhang, et al. · Advanced Healthcare Materials · 26
Aurora kinase A regulates liver regeneration through macrophages polarization and Wnt/β‐catenin signalling
2021 · Yanze Yin, Defu Kong, et al. · Liver International · 26
PDF
Inhibition of GSK‐3β induces AP‐1‐mediated osteopontin expression to promote cholestatic liver fibrosis
2018 · Shaoyong Zhuang, Xiangwei Hua, et al. · The FASEB Journal · 25
DJ-1 deficiency attenuates expansion of liver progenitor cells through modulating the inflammatory and fibrogenic niches
2016 · L Chen, M Luo, et al. · Cell Death and Disease · 25
PDF
Karonudib is a promising anticancer therapy in hepatocellular carcinoma
2019 · Xiangwei Hua, Kumar Sanjiv, et al. · Therapeutic Advances in Medical Oncology · 24
PDF
Safety and efficacy of sorafenib therapy in patients with hepatocellular carcinoma: final outcome from the Chinese patient subset of the GIDEON study
2015 · Sheng-Long Ye, Xiaoping Chen, et al. · Oncotarget · 24
PDF
Identification and Validation of a Potent Multi-mRNA Signature for the Prediction of Early-Relapse in Hepatocellular Carcinoma
2018 · Jie Cai, Ying Tong, et al. · Carcinogenesis · 23
Patient-derived models facilitate precision medicine in liver cancer by remodeling cell-matrix interaction
2023 · Kaiwen Chen, Yanran Li, et al. · Frontiers in Immunology · 21
PDF
Salvage Liver Transplantation Leads to Poorer Outcome in Hepatocellular Carcinoma Compared with Primary Liver Transplantation
2017 · Yuhua Shan, Lifeng Huang, et al. · Scientific Reports · 21
PDF
Works count: 78
Citation count: 1,260
H-index: 23
I10-index: 33
Year
Topic
Type